| Tag | Content |
|---|
EnhancerAtlas ID | HS176-31892 |
Organism | Homo sapiens |
Tissue/cell | SK-N-SH |
Coordinate | chr5:76097050-76098010 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| RREB1 | MA0073.1 | chr5:76097349-76097369 | GGGAGGCTGGTGTTTTGGGT | - | 6.84 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_02376 | chr5:76096761-76098209 | Astrocytes | | SE_34546 | chr5:76096989-76097799 | HCT-116 | | SE_36755 | chr5:76096689-76098156 | HMEC | | SE_38350 | chr5:76096592-76098249 | HUVEC | | SE_46266 | chr5:76096359-76098327 | Osteoblasts |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH05I076800 | chr5 | 76096637 | 76097826 |
|
Enhancer Sequence | GAAGAAGAAA TTAAAGTGCT TGATGTATTT TAGAAGTTAC AAGTAGGCCT GTGTGGCTGG 60
AGAGAGCATG GAAGGGAAGA GTGGGAGGAG AGGAGCACAG AGGGCCGGAA GTTAATCCTG 120
CAGGGGACCT TTGGCTTTTG CTCTGAGTTA GACGTGAGCC TTGGAGAGTT TGCACAGAAA 180
TGGGCCAAGG TCTGGTTTAC CTTCTTAAGG ATAACTCAGG CTTCTCTGTG AGGGCTGGAA 240
TGCAGGAGAC AGGGTTGGGC AAAAGGAAAC CAGCTGAGAG GCTATTGAGA ACTGGGAAAG 300
GGAGGCTGGT GTTTTGGGTG AGGGTGGGAG CAAGAGGAAA TTGCAAAAGT TTATCTTGTT 360
CCGGAAATAT TTTGAAGGTA GAGCCAAAAG GATTTGCTGA TGGGTTGGAT GGGAGAGAAA 420
GTGAGTAGTC AGGATGACAT GCCTTCCAAG CCTTTTGGCC AGACAAGCTG GGATGGCTGC 480
CAGTTATTAA GACCGGGAAG ACTTCTTGAG AAGAACCTCT TTGAGGATGG AATTCAAAAG 540
CTTGGCTTTG GACACATTAG TTTGAGATGA CTATTAGGAT ATACAATATC CTAATTGTAC 600
TGGGGACAGT AGTTATCAAA GTAAAGATAG TAAAGATAGT AATTAAAGTT ACAGGACTGG 660
ATGAGATCAC CTAGAGAGTG GTCACAGGTA GAAAAGATAT CTGACCCTCA GGGCTCTCCA 720
GTGTGTGGAG GAGGAGGCTG CAAAATAGAT TGACAAGGAG CAGCCAAGGA GGGAGGAGGA 780
GAGTCCAGAG ACAGCAGTAT TCTAGAAGCC AACCGCTGCC GAGAGGGGAG CAAGACAGAC 840
ACTGAAGGTT AACTGTTGCA TTTGGCATGA TAGATAGAGT AGTGGGGATG GACGCCTGGT 900
GTCCCTATCA GCATTTGATG GGAAAAAAAT GGGAGGGGAT GAGGAGATAG CAAGAGCAGA 960
|
